Treatment of obesity: Cost-benefit assessment of behavioral therapy, placebo, and two anorectic drugs

W. T. Dahms, M. E. Molitch, G. A. Bray, F. L. Greenway, R. L. Atkinson, K. Hamilton

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Mazindol, diethylpropion, and a placebo were compared with behavioral therapy for effectiveness in producing weight reduction in an outpatient obesity clinic. Each method was also compared in cost and harmful side effects. The patients were recruited from the middle and lower socioeconomic groups. Of the 120 patients beginning treatment, only 33 completed the entire 14-week study. There was no statistically significant difference in the weight loss among the treatment groups. The program of behavioral therapy was administered by a dietitian who was experienced in the techniques of behavior modification; the drug treatment groups were seen by physicians. The authors conclude that behavioral therapy may be the treatment of choice in an outpatient obese population since it requires little physician time, is less expensive, and avoids the side effects of anorectic drugs.

Original languageEnglish (US)
Pages (from-to)774-778
Number of pages5
JournalUnknown Journal
Volume31
Issue number5
DOIs
StatePublished - 1978

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'Treatment of obesity: Cost-benefit assessment of behavioral therapy, placebo, and two anorectic drugs'. Together they form a unique fingerprint.

  • Cite this